Join
Live feed
·
PRReleasevia Quantisnow
CERo Therapeutics Holdings Inc. logo

CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays

ByQuantisnow·Wall Street's wire, on your screen.
CERO· CERo Therapeutics Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERO (CERo Therapeutics Holdings Inc.) and more on Quantisnow.